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Fibrosis is a common outcome 
following total knee arthroplasty
Nicole Abdul1, David Dixon1, Andrew Walker1, Joanna Horabin1, Nick Smith1, 
David J. Weir2, Nigel T. Brewster2, David J. Deehan1,2, Derek A. Mann1 & Lee A. Borthwick1
Total knee arthroplasty (TKA) is one of the most successful orthopaedic procedures that alleviates 
pain and restores function in patients with degenerative knee joint diseases. Arthrofibrosis, 
abnormal scarring in which dense fibrous tissue prevents normal range of motion, develops in 
~3–10% of TKA patients. No prophylactic intervention is available and treatment is restricted 
to aggressive physiotherapy or revision surgery. Tissue was collected from patients undergoing 
primary (n = 30) or revision (n = 27) TKA. Revision patients were stratified as non-arthrofibrotic and 
arthrofibrotic. Tissue was macroscopically and histologically compared to improve our understanding 
of the pathophysiology of arthrofibrosis. Macroscopically, tissue from primary TKA presents as 
homogenous, fatty tissue whereas tissue from revision TKA presents as dense, pigmented tissue. 
Histologically, there was dramatic tissue remodelling, increased collagen deposition and increased 
(myo)fibroblast staining in tissue from revision TKA. Significantly, tissue architecture was similar 
between revision patients regardless of clinically diagnosis. There are significant differences in 
architecture and composition of tissue from revision TKA over primary TKA. Surprisingly, whether 
revision TKA were clinically diagnosed as arthrofibrotic or non-arthrofibrotic there were still 
significant differences in fibrotic markers compared to primary TKA suggesting an ongoing fibrotic 
process in all revision knees.
Total knee arthroplasty (TKA) is one of the most successful orthopaedic procedures that reliably allevi-
ates pain and restores function in patients who have degenerative knee joint diseases including osteoar-
thritis and rheumatoid arthritis. A recent audit revealed that 153,133 primary knee arthroplasties were 
performed in 396 centres throughout England and Wales in a 2-year period (01/07/2008–30/06/2010)1 
and over 1.5 million are performed worldwide each year2. The surgery involves the resection of diseased 
or damaged bone from intra-articular areas of the knee followed by attachment of metal and polyeth-
ylene prosthetic replacements. Success rates for the operation are very high resulting in a substantial 
restoration of function and alleviation of pain and associated morbidity3. However, although a very high 
success rate is observed with TKA surgery, some 3–10% of individuals go on to develop fibrosis in the 
form of arthrofibrosis post-surgery4–6.
Arthrofibrosis, defined as abnormal scarring of the joint in which the formation of dense fibrous 
tissue and tissue metaplasia prevents normal range of motion, represents a significant clinical challenge 
and drastically reduces quality of life of those affected individuals5. Arthrofibrosis has been described 
as a fibrosing pathology of the synovial membrane7 and the infrapatellar fat pad8 with several studies 
highlighting an important role for the infrapatellar fat pad in regulating the function of the knee. For 
example Richmond and al Assal have described that Infrapatellar Contracture Syndrome (IPCS) is asso-
ciated with knee surgery and that resection of the fibrotic fat pad can increase total range of movement9 
and a recent review by Dragoo et al. highlights that inflammation and fibrosis within the infrapatellar 
fat pad caused by trauma and/or surgery, can lead to a variety of arthrofibrotic lesions including Hoffa’s 
disease, anterior interval scarring and IPCS10.
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Fibroblasts are the most abundant cell in connective tissue and have been shown to play a critical role 
in physiological wound healing and restoration of tissue architecture. However, fibroblasts have also been 
shown to be one of the major effector cells involved in pathological wound repair and the development 
of fibrosis in multiple organs11–14. Significantly, the number of α -smooth muscle actin containing fibro-
blastic cells has been shown to be elevated in patients with arthrofibrosis after anterior cruciate ligament 
reconstruction suggesting a potentially important role for these cells in the development of fibrosis in 
the knee15.
To date, no prophylactic intervention is available and treatment for arthrofibrosis is restricted to 
aggressive physiotherapy or revision surgery16,17. Revision surgery puts the patient at risk of complica-
tions such as risks from undergoing an anaesthetic, infection, bleeding, damage to structures around the 
knee and pain amongst others. Revision surgery also comes at a great cost to the NHS including surgeon’s 
time, theatre use, theatre staff, equipment, postoperative high dependency bed and physiotherapy18.
Research investigating the mechanisms regulating/driving the development of arthrofibrosis following 
TKA is extremely limited and urgently needed to improve our understanding of the pathophysiology of 
arthrofibrosis and potentially lead to further studies investigating the feasibility of therapeutic targets to 
limit/reverse disease. In this study we macroscopically and histologically compare and contrast the tissue 
architecture and composition of the synovial membrane and infrapatellar fat pad of patients undergo-
ing primary TKA, patients undergoing revision TKA for non-arthrofibrotic complications and patients 
undergoing revision TKA for the development of arthrofibrosis to improve our understanding of the 
pathophysiology of arthrofibrosis.
Materials and Methods
Patient recruitment and ethics. This study was performed in accordance with approval from the 
Newcastle and North Tyneside Local Regional Ethics Committee and informed written consent from all 
study patients (12/NE/0395).
Tissue collection and processing. Infrapatellar fat pad and suprapatellar synovium (suprapatellar 
pouch) were collected from patients undergoing either primary TKA (n = 30) or patients undergoing 
revision TKA (n = 27). For the purposes of this study we chose these two surgical sites as reliable posi-
tions within the knee of early fibrotic response7–10. Patients undergoing revision TKA were stratified 
into non-arthrofibrotic revisions (n = 15) and arthrofibrotic revisions (n = 12). For the purposes of our 
study we accepted a definition of primary arthrofibrosis as occurring in the absence of infection (normal 
pre op CRP, apyrexial, no history of night sweats or of previous local or systemic infection), absence of 
component malalignment or gross over stuffing of the patellofemoral articulation, absence of heterotic 
ossification and/or evidence of shortening of the patella tendon on radio graphic assessment, patella teth-
ering with thickened retinaculum, no neuromuscular disorder, no previous history of a fibrotic reaction 
in another joint or muscle complex, no history of dupuytren’s disease, no previous treatment for frozen 
shoulder, no features of reflex sympathetic dystrophy and with persistent loss of arc range of movement 
< 90° when there had been a recorded history of greater active movement, and on table significant intra 
articular scarring present in 2 or more distinct anatomical sites19.
Tissue was stored at 4 °C in tissue culture media containing 10% FCS, 1% L-glutamine, 100units/ml 
penicillin and 100 μ g/ml streptomycin prior to processing. Representative tissue biopsies (2× ~ 1 cm3) 
were fixed in 10% neutral buffered formalin overnight and paraffin embedded. Serial tissue sections 
(5 μ m) were cut and processed for staining as described below.
Picrosirius red staining. Tissue sections (5 μ m) were deparaffinized in xylene, rehydrated in graded 
alcohol, and rinsed in water. Sections were treated in phosphomolybdic acid (0.2% aqueous) for 5 mins 
before staining in 0.1% sirius red F3B in saturated picric acid for 90 mins. After staining the sections were 
washed in 0.01N hydrochloric acid, dehydrated in graded alcohol and mounted in Pertex (3808706E 
Leica).
Immunohistochemistry. Tissue sections (5 μ m) were deparaffinized in xylene, rehydrated in graded 
alcohol, and incubated in 0.6% hydrogen peroxide/methanol for 15 minutes. Antigen retrieval was per-
formed in proteinase K (20 μ g/ml in PBS) for 30 mins at 37 °C or sodium citrate buffer (H3300, Vector 
Laboratories) for 20 mins in a microwave. Sections were blocked with avidin/biotin (SP-2001, Vector 
Laboratories) for 20 mins, then with 20% pig serum in PBS for 30 mins. Slides were incubated overnight 
at 4 °C with goat primary antibodies against collagen I (1/50 dilution - 1310-01, Southern Biotech), 
collagen III (1/50 dilution - 1330-01, Southern Biotech), vimentin (1/100 dilution, M7020, Dako) and 
fibronectin (1/250 dilution, F3648, Sigma) in 5% pig serum PBS or a FITC conjugated mouse mono-
clonal antibody against α -smooth muscle actin (α -SMA) (F3777, Sigma) at 1/1000 dilution in 5% pig 
serum PBS. Slides were washed with PBS and were incubated with biotinylated rabbit anti-sheep (BA-
6000, Vector Laboratories) or biotinylated goat anti-fluorescein (BA-0601, Vector Laboratories) in 1% 
pig serum for 2 hours. Amplification of antigen was achieved using an R.T.U. Vectastain kit (PK-7100, 
Vector Laboratories) and positive staining was visualized by 3,3- diaminobenzidine tetrahydrochloride 
(SK-4100, Vector laboratories).
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Image analysis. Images were acquired on a Nikon Eclipse upright microscope. For image quantifica-
tion, the mean percentage area positive for 10× randomly selected high powered fields (×10 magnifica-
tion) was calculated using Nikon NIS elements image analysis software.
Hydroxyproline assay. For assessment of fibrosis, in patients where sufficient tissue was available, 
hydroxyproline was measured as a surrogate for collagen content as previously described20. Briefly, 5–7 
small biopsies (total weight ~200 mg) were collected from throughout the tissue and digested with 1ml 
of 6N HCl at 110 °C for 18 hours. Following digestion the sample is neutralised in 10N NaOH before 
colorization with Ehrlich’s reagent. A standard curve comprised of dilutions of 1mM hydroxyproline was 
used for quantification.
Statistical analysis. Differences in the concentration of hydroxyproline (nmol/g) and the percent-
age (%) picrosirius red, collagen I, collagen III, vimentin, fibronectin and smooth muscle actin positive 
staining of synovial membrane and infrapatellar fat pad between patient subgroups (1. primary TKA 
patients & non-arthrofibrotic revision TKA patients, 2. primary TKA patients & arthrofibrotic revision 
TKA patients, and 3. non-arthrofibrotic revision TKA patients & arthrofibrotic revision TKA patients) 
were assessed in GraphPad prism version 6 (GraphPad Software, Dan Diego, CA) using a Mann-Whitney 
U-test. Differences with a p-value of  <0.05 were considered statistically significant.
Results
Patient selection and tissue acquisition. Patients undergoing primary TKA (n = 30) and revision 
TKA (n = 27) at Freeman hospital, Newcastle upon Tyne were consented to the study. Patients undergo-
ing revision surgery were stratified as those without arthrofibrosis (n = 15) and those with arthrofibrosis 
(n = 12) (see Table 1).
After eversion of the patella, prior to bone cuts (primary) or implant removal (revision) the infrap-
atellar fat pad or residuum is sectioned longitudinally whilst preserving the patellar tendon. This tissue 
is cautiously elevated off the tendon with a scalpel and removed from both the medial and lateral halves 
judiciously. In the native setting the suprapatellar pouch is identified centrally above the trochlea lying 
deep to the overlying quadriceps apparatus. In the revision setting it is visualised as an adherent anatom-
ically equivalent adnexal mass lying above the primary femoral component anteriorly. See Fig. 1a for a 
visual representation of the location the tissues are sampled from.
Macroscopic appearance of an arthrofibrotic knee. Figure  1bi represents an arthroscopic view 
of an aberrant fibrous band bridging the space between the suprapatellar pouch roof with evidence of 
neovascularisation in a patient with severe arthrofibrosis. Figure  1bii represents an arthroscopic view 
of surgical cautery with a diathermy probe of dense layered adhesions lying within the lateral synovial 
gutter of the knee.
Macroscopically, the synovial membrane and infrapatellar fat pad collected from primary TKA patients 
appeared to be homogenous, fatty tissue (Fig. 2, left panel). In contrast, tissue from patients undergoing 
non-arthrofibrotic revision TKA (Fig. 2, middle panel) and patients undergoing arthrofibrotic revision 
TKA (Fig. 2, right panel) appeared to be dense, pigmented tissue. In additional primary tissue would float 
in tissue culture media whereas revision tissue was, for the majority of samples, submerged confirming 
an increased density in the revision tissue.
Sex (M:F)
Age 
(median(range))
Time from primary 
to revision TKA 
(median(range)) Primary indication for surgery
Primary TKA (n = 30) 17M:13F 66 years (44–81) N/A Osteoarthrosis (n = 29), Rheumatoid disease (n = 1)
Non-arthrofibrotic revision TKA (n = 15) 5M:10F 74 years (40–82) 10 years (2–20)
Osteolysis and loose components 
(n = 9), Primary laxity pattern 
with functional instability (n = 3), 
Progression of osteoarthrosis 
(previous patellofemoral 
resurfacing) (n = 2), Revision for 
femoral medial condyle nonunion 
and pain (n = 1)
Arthrofibrotic revision TKA (n = 12) 6M:6F 69 years (44–88) 4 years (3–10)
Loss of movement with functional 
deficit, significant pain with 
activity (n = 11), Loss of 
movement with functional deficit, 
significant pain with activity and 
significant bone loss (n = 1)
Table 1.  Patient demographics.
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Increased collagen deposition in revision TKA. To quantify the degree of fibrosis in the tissue 
from primary and revision TKA patients we measured hydroxyproline content as a surrogate for levels 
of collagen. We found a significant increase in the tissue concentration of collagen in patients undergoing 
Figure 1. Arthroscopic evidence of arthrofibrosis in the knee. (a) Magnetic resonance image (MRI) 
of a knee joint. Red arrows indicate the location of the suprapatellar synovium and infrapatellar fat 
pad. (b) Arthroscopic view of an aberrant fibrous band bridging the space between the suprapatellar pouch 
roof (R) with evidence of neovascularisation (nV) and the superior articular margin of the trochlea (T) in a 
patient with severe arthrofibrosis (i). Surgical cautery with a diathermy probe (P) of dense layered adhesions 
(A) lying within the lateral synovial gutter of the knee (ii).
Figure 2. Macroscopic evaluation of tissue from primary and revision TKA. Synovial membrane (upper 
panel) and infrapatellar fat pad (lower panel) were isolated from patients undergoing primary TKA (left 
panel), patients undergoing non-arthrofibrotic revision TKA (middle panel) and patients undergoing 
arthrofibrotic revision TKA (right panel). Both tissues from primary TKA patients appeared to be 
homogenous, fatty, non-fibrotic tissue. In contrast, tissue from revision TKA patients appeared to be dense, 
pigmented, fibrotic tissue regardless of clinical diagnosis. Images acquired by Dr Lee Borthwick.
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Figure 3. Significant tissue remodelling and collagen deposition following TKA. (a) In patients where 
sufficient tissue was available, hydroxyproline was measured as a surrogate for collagen content in tissue. There 
was a significant increase in the hydroxyproline content of synovial membrane (i) and infrapatellar fat pad (ii) 
from revision patients compared to primary TKA. There was no significant difference in the hydroxyproline 
content of either tissue between patients undergoing non-arthrofibrotic revision TKA and patients undergoing 
arthrofibrotic revision TKA. Synovial membrane; primary TKA n = 29, non-arthrofibrotic revision TKA n = 14, 
arthrofibrotic revision TKA n = 12. Infrapatellar fat pad; primary TKA n = 28, non-arthrofibrotic revision TKA 
n = 15, arthrofibrotic revision TKA n = 10. *p < 0.05. ***p < 0.001. (b) Representative images of picrosirius red 
stained synovial membrane (upper panel) and infrapatellar fat pad (lower panel) from patients undergoing 
primary TKA (left panel), patients undergoing non-arthrofibrotic revision TKA (middle panel) and patients 
undergoing arthrofibrotic revision TKA (right panel). There is evidence of significant tissue remodelling 
characterised by the loss of fat cells and the deposition of large quantities of densely packed collagen fibres in 
both tissues isolated from patients undergoing revision TKA regardless of clinical diagnosis. Images acquired 
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non-arthrofibrotic revision TKA (synovial membrane - 523 (74–1206) nmol/g, p = 0.03; infrapatellar 
fat pad - 546 (135–1042) nmol/g, p < 0.001) and patients undergoing arthrofibrotic revision TKA (syn-
ovial membrane - 674 (274–1478) nmol/g; p < 0.001; infrapatellar fat pad - 763 (170–1269) nmol/g, 
p < 0.001) compared to primary TKA (synovial membrane - 281 (32–883) nmol/g; infrapatellar fat pad 
- 244 (89–907) nmol/g). Surprisingly, there was no statistically significant difference (synovial membrane 
- p = 0.16; infrapatellar fat pad – p = 0.12) in the concentration of collagen between patients undergoing 
non-arthrofibrotic revision TKA and patients undergoing arthrofibrotic revision TKA , although a trend 
towards increased concentration of collagen in patients undergoing arthrofibrotic revision TKA was 
observed (Fig. 3a).
Picrosirius red staining (Fig. 3b,c) and immunohistochemistry for collagen I (Fig. 4) and collagen III 
(Fig. 5) were used to confirm the increase in collagen in revision TKA patients and to investigate its dis-
tribution within the tissue. Both the synovial membrane and infrapatellar fat pad isolated from primary 
TKA are characterised by a homogenous distribution of white adipocytes (fat cells) with small amounts 
of collagen I distributed around adipocytes (Figs 3b and 4 left panel) and fibrotic bands of collagen III 
distributed throughout the tissue (Figs  3b and 5 left panel). For all stains there is evidence of signifi-
cant tissue remodelling characterised by the loss of adipocytes and the deposition of large quantities of 
densely packed collagen I (Figs 3b and 4 middle and right panel) and collagen III (Figs 3b and 5 middle 
and right panel) fibres in both patients undergoing non-arthrofibrotic revision TKA and patients under-
going arthrofibrotic revision TKA.
There was a significant increase in the percentage positive staining for picrosirius red (Fig. 3c), col-
lagen 1 (Fig.  4b) and collagen III (Fig.  5b) in patients undergoing non-arthrofibrotic revision TKA 
(picrosirius red: synovial membrane – 50 (20–79) %, p < 0.01; infrapatellar fat pad – 68 (51–88) %, 
p < 0.05) (collagen I: synovial membrane – 46 (23–70) %, p < 0.001; infrapatellar fat pad – 66 (43–88) %, 
p < 0.01;) (collagen III: synovial membrane – 16 (11–24) %, p < 0.01; infrapatellar fat pad – 15 (13–18) 
%, p < 0.01;) and patients undergoing arthrofibrotic revision TKA (picrosirius red: synovial membrane 
– 44 (20–73) %, p < 0.01; infrapatellar fat pad – 82 (68–95) %, p < 0.01) (collagen I: synovial membrane – 
42 (22–65) %, p < 0.001; infrapatellar fat pad – 79 (64–98) %, p < 0.01;) (collagen III: synovial membrane 
– 15 (12–24) %, p < 0.01; infrapatellar fat pad – 18 (16–24) %, p < 0.05;) compared to primary TKA 
(picrosirius red: synovial membrane - 13 (2.0–30) %; infrapatellar fat pad – 20 (2.4–89) %) (collagen I: 
synovial membrane – 8.6 (2.9–21) %; infrapatellar fat pad – 14 (2.9–71) %) (collagen III: synovial mem-
brane – 10 (8–14) %; infrapatellar fat pad – 11 (8–21) %). There was no statistically significant difference 
in picrosirius red (synovial membrane - p = 0.53; infrapatellar fat pad – p = 0.22), collagen I (synovial 
membrane - p = 0.67; infrapatellar fat pad – p = 0.41), and collagen III (synovial membrane - p = 0.41; 
infrapatellar fat pad – p = 0.06) staining between patients undergoing non-arthrofibrotic revision TKA 
and patients undergoing arthrofibrotic revision TKA.
The comparable level and distribution of collagen seen between the two groups of revision TKA 
patients confirms the biochemical data generated above (Fig. 3a).
Increased α-smooth muscle actin expression in revision TKA. Fibroblasts are cells of distinct 
morphology that are responsible for the maintenance and deposition of extracellular matrix throughout 
the body and play a critical role in physiological wound repair. However fibroblasts, in particular α -SMA 
positive myofibroblasts, have also been identified as one of the major effector cells in pathological wound 
repair and the subsequent development of fibrosis in multiple tissues/organs12–14. We therefore proceeded 
to stain synovial membrane and infrapatellar fat pad from primary and revision TKA for vimentin and 
fibronection to determine the level of fibroblasts present and α -SMA to determine the levels of myofi-
broblasts present. There was a significant increase in the percentage positive staining for vimentin (Fig. 6) 
and fibronectin (Fig.  7) in patients undergoing non-arthrofibrotic revision TKA (vimentin: synovial 
membrane – 13 (4.0–22) %, p < 0.0001; infrapatellar fat pad – 9.8 (0.6–19) %, p < 0.001) (fibronectin: 
synovial membrane – 6.0 (2.0–7.8) %, p < 0.0001; infrapatellar fat pad – 9.4 (6.8–15) %, p < 0.0001;) 
and patients undergoing arthrofibrotic revision TKA (vimentin: synovial membrane – 9.6 (7.1–12) %, 
p < 0.0001; infrapatellar fat pad – 8.6 (5.1–15) %, p < 0.0001) (fibronectin: synovial membrane – 6.6 
(3.6–12.7) %, p < 0.0001; infrapatellar fat pad – 7.5 (2.9–12) %, p < 0.0001;) compared to primary TKA 
(vimentin: synovial membrane - 0.8 (0.4–1.3) %; infrapatellar fat pad – 0.8 (0.3–1.1) %) (fibronectin: 
synovial membrane – 1.4 (0–2.2) %; infrapatellar fat pad – 1.4 (0.1–2.3) %). Figure 8 shows that there 
was a significant increase in α -SMA positive staining in patients undergoing non-arthrofibrotic revision 
TKA (synovial membrane - 4.3 (0.8–8.7) %, p < 0.03; infrapatellar fat pad - 4.2 (2.5–6.7) %, p < 0.001) 
on a Nikon inverted microscope at 10× magnification. (c) Picrosirius red positive staining was quantified using 
image analysis software. There was a significant increase in picrosirius red positive staining of synovial membrane 
(i) and infrapatellar fat pad (ii) from revision patients compared to primary TKA regardless of clinical diagnosis. 
There was no significant difference in picrosirius red positive staining of either tissue between patients undergoing 
non-arthrofibrotic revision TKA and patients undergoing arthrofibrotic revision TKA. Synovial membrane and 
Infrapatellar fat pad; primary TKA n = 9, non-arthrofibrotic revision TKA n = 10, arthrofibrotic revision TKA 
n = 10. *p < 0.05, **p < 0.01.
www.nature.com/scientificreports/
7Scientific RepoRts | 5:16469 | DOI: 10.1038/srep16469
and patients undergoing arthrofibrotic revision TKA (synovial membrane - 8.1 (0.8–9.8) %, p < 0.03; 
infrapatellar fat pad - 6.2 (3.0–8.5) %, p < 0.001) compared to primary TKA (synovial membrane - 0.9 
(0.6–2.4) %; infrapatellar fat pad – 0.5 (0.1–1.9) %, p < 0.001).
There was no statistically significant difference in vimentin (synovial membrane - p = 0.16; infrap-
atellar fat pad – p = 0.57), fibronectin (synovial membrane - p = 0.99; infrapatellar fat pad – p = 0.35), 
and α -SMA (synovial membrane - p = 0.67; infrapatellar fat pad – p = 0.15) staining between patients 
undergoing non-arthrofibrotic revision TKA and patients undergoing arthrofibrotic revision TKA.
Discussion
Our data demonstrates that tissue isolated from patients undergoing revision TKA, regardless of clinical 
diagnosis, is macroscopically and histologically different from tissue isolated from patients undergoing 
Figure 4. Collagen I is significantly increased in tissue from revision TKA. Representative images of 
collagen I stained synovial membrane (upper panel) and infrapatellar fat pad (lower panel) from patients 
undergoing primary TKA (left panel), patients undergoing non-arthrofibrotic revision TKA (middle 
panel) and patients undergoing arthrofibrotic revision TKA (right panel). There is a significant increase in 
collagen I expression in revision TKA tissue compared to primary TKA tissue. Images acquired on a Nikon 
inverted microscope at 10× magnification. (b) Collagen I positive staining was quantified using image 
analysis software. There was a significant increase in collagen I positive staining of synovial membrane 
(i) and infrapatellar fat pad (ii) from revision patients compared to primary TKA regardless of clinical 
diagnosis. There was no significant difference in collagen I positive staining of either tissue between 
patients undergoing non-arthrofibrotic revision TKA and patients undergoing arthrofibrotic revision TKA. 
Synovial membrane and Infrapatellar fat pad; primary TKA n = 9, non-arthrofibrotic revision TKA n = 10, 
arthrofibrotic revision TKA n = 10. **p < 0.01, ***p < 0.001.
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primary TKA, with evidence of significant tissue remodelling characterised by loss/replacement of adi-
pocytes with dense areas of collagen. Furthermore, regardless of whether revision patients were clinically 
stratified as non-arthrofibrotic or arthrofibrotic there was still dramatic evidence of tissue remodelling 
suggesting that an ongoing fibrotic process is occurring in most, if not all, revision knees. Validation of 
our observations in future studies with a larger patient cohort will be of great importance.
Significantly, and of great interest, is the question of why this fibrosis leads to a reduction in arc of 
motion in some patients and not others. To begin to address this question we must consider the limita-
tions of this study. Firstly, our study has investigated the concentration of collagen in the tissue samples 
we received from the patients. This provides very accurate information regarding the density of collagen 
in the tissue but provides little detail regarding the total amount of collagen/scar tissue found in the 
knee. Perhaps the amount rather than the density of the fibrosis defines an effect on arc of motion? 
Furthermore we have so far only measured collagen content in two tissues and investigating fibrosis in 
other anatomical locations within the knee, for example the posterior capsule, is required. Addressing 
Figure 5. Increased collagen III expression in revision TKA tissue. Representative images of collagen III 
stained synovial membrane (upper panel) and infrapatellar fat pad (lower panel) from patients undergoing 
primary TKA (left panel), patients undergoing non-arthrofibrotic revision TKA (middle panel) and patients 
undergoing arthrofibrotic revision TKA (right panel). Collagen III expression is significant increase in 
revision TKA tissue compared to primary TKA tissue. Images acquired on a Nikon inverted microscope at 
10× magnification. (b) Collagen III positive staining was quantified using image analysis software. There was 
a significant increase in collagen III positive staining of synovial membrane (i) and infrapatellar fat pad (ii) 
from revision patients compared to primary TKA regardless of clinical diagnosis. There was no significant 
difference in collagen III positive staining of either tissue between patients undergoing non-arthrofibrotic 
revision TKA and patients undergoing arthrofibrotic revision TKA. Synovial membrane and Infrapatellar 
fat pad; primary TKA n = 9, non-arthrofibrotic revision TKA n = 10, arthrofibrotic revision TKA n = 10. 
*p < 0.05, **p < 0.01.
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these questions in future studies will improve our understanding of the development of arthrofibrosis 
following TKA.
The infrapatellar fat pad occupies the space formed by the patella, patellar tendon, tibial plateau, and 
the femoral condyles21 and is only metabolised in severe malnutrition, implying an essential role in joint 
function22. In addition the infrapatellar fat pad had been hypothesised to play a key role in the supply of 
blood to the patellar tendon, the biomechanics of the knee joint, as well as being a modulator of inflam-
matory responses around the knee23–25. However, despite the evidence for an important biological role, 
the removal of the infrapatellar fat pad during TKA remains a matter of surgeon preference. A recent 
study from Moverley et al. investigated the 1 year postoperative outcomes of patients with total or partial 
excision of the infrapatellar fat pad versus patients in which the infrapatellar fat pad was preserved26. The 
data demonstrates that patients in which the infrapatellar fat pad was preserved had significantly better 
Oxford Knee Scores (OKS) associated with rising from a chair, pain, limping and giving way, further 
highlighting an important role for the infrapatellar fat pad in vivo. The infrapatellar fat pad was partially 
Figure 6. Increased expression of vimentin positive cells in tissue from revision TKA. (a) Representative 
images of vimentin stained synovial membrane (upper panel) and infrapatellar fat pad (lower panel) from 
patients undergoing primary TKA (left panel), patients undergoing non-arthrofibrotic revision TKA (middle 
panel) and patients undergoing arthrofibrotic revision TKA (right panel). Vimentin staining is increase in 
revision TKA tissue compared to primary TKA tissue. Images acquired on a Nikon inverted microscope at 
20× magnification. (b) Vimentin positive staining was quantified using image analysis software. There was 
a significant increase in vimentin positive staining of synovial membrane (i) and infrapatellar fat pad (ii) 
from revision patients compared to primary TKA regardless of clinical diagnosis. There was no significant 
difference in vimentin positive staining of either tissue between patients undergoing non-arthrofibrotic 
revision TKA and patients undergoing arthrofibrotic revision TKA. Synovial membrane and Infrapatellar 
fat pad; primary TKA n = 9, non-arthrofibrotic revision TKA n = 10, arthrofibrotic revision TKA n = 10. 
***p < 0.001, ****p < 0.0001.
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removed from all revision patients included in this study during their primary TKA. Our data suggests 
that the void in the intraarticular space created by the removal of the infrapatellar fat pad is being filled 
by either the pathological expansion/proliferation of the residual tissue and/or by the deposition of large 
amounts of extracellular matrix proteins such as collagen I/III. Research comparing the architecture of 
tissue from revision patients in which the infrapatellar fat pad was excised or preserved at primary TKA 
is required to further investigate this hypothesis. However it is clear that the infrapatellar fat pad is not 
simply an inert structure that can be ignored when we consider the development of arthrofibrosis.
Our data also highlights a significant increase in α -SMA positive staining in tissue isolated from 
revision TKA compared to primary TKA, indicating an increase in the number of myo-fibroblasts in the 
tissue. Our data is in agreement with Unterhauser et al. who reported a 10 fold increase in the frequency 
of α -SMA containing contractile fibroblastic cells in knee arthrofibrotic tissue after anterior crucial lig-
ament reconstruction15. Furthermore there is a non-statistically significant trend towards an increase in 
α -SMA positive staining in tissue isolated from arthrofibrotic TKA compared to tissue isolated from 
Figure 7. Increased expression of fibronectin positive cells in tissue from revision TKA. (a) 
Representative images of fibronectin stained synovial membrane (upper panel) and infrapatellar fat pad 
(lower panel) from patients undergoing primary TKA (left panel), patients undergoing non-arthrofibrotic 
revision TKA (middle panel) and patients undergoing arthrofibrotic revision TKA (right panel). Fibronectin 
staining is increase in revision TKA tissue compared to primary TKA tissue. Images acquired on a Nikon 
inverted microscope at 20× magnification. (b) Fibronectin positive staining was quantified using image 
analysis software. There was a significant increase in fibronectin positive staining of synovial membrane 
(i) and infrapatellar fat pad (ii) from revision patients compared to primary TKA regardless of clinical 
diagnosis. There was no significant difference in fibronectin positive staining of either tissue between 
patients undergoing non-arthrofibrotic revision TKA and patients undergoing arthrofibrotic revision TKA. 
Synovial membrane and Infrapatellar fat pad; primary TKA n = 9, non-arthrofibrotic revision TKA n = 10, 
arthrofibrotic revision TKA n = 10. ****p < 0.0001.
www.nature.com/scientificreports/
1 1Scientific RepoRts | 5:16469 | DOI: 10.1038/srep16469
non-arthrofibrotic TKA suggesting an ongoing fibrotic process and a potentially important role for these 
cells in disease pathology. Further investigating differences in protein and gene expression of key fibro-
genic markers in tissue from primary and revision TKA will greatly improve our understanding of the 
remodelling process in the knee.
Currently no prophylactic intervention is available for arthrofibrosis and therefore treatment is 
restricted to aggressive physiotherapy or revision surgery. However an encouraging pilot study from 
Brown et al. demonstrated that intra-articular injection of Anakinra, an IL-1R antagonist, into patients 
with arthrofibrosis improved range of movement and swelling, with the majority also reporting a reduc-
tion in pain and a return to prior activity levels, however the mechanism of action is unknown27. Previous 
work in our laboratory has identified that fibroblasts isolated from human lung tissue express a high level 
of IL-1R and are strongly activated by treatment with IL-1α . Furthermore mice lacking IL-1α or IL-1R 
are protected from bleomycin induced fibrosis in the lung28. These observations, together with our data 
Figure 8. Increased expression of α-SMA positive cells in tissue from revision TKA. (a) Representative 
images of α -SMA stained synovial membrane (upper panel) and infrapatellar fat pad (lower panel) from 
patients undergoing primary TKA (left panel), patients undergoing non-arthrofibrotic revision TKA (middle 
panel) and patients undergoing arthrofibrotic revision TKA (right panel). α -SMA staining is increase in 
revision TKA tissue compared to primary TKA tissue. Images acquired on a Nikon inverted microscope 
at 20x magnification. (b) α -SMA positive staining was quantified using image analysis software. There was 
a significant increase in α -SMA positive staining of synovial membrane (i) and infrapatellar fat pad (ii) 
from revision patients compared to primary TKA regardless of clinical diagnosis. There was no significant 
difference in α -SMA positive staining of either tissue between patients undergoing non-arthrofibrotic 
revision TKA and patients undergoing arthrofibrotic revision TKA. Synovial membrane and Infrapatellar 
fat pad; primary TKA n = 10, non-arthrofibrotic revision TKA n = 5, arthrofibrotic revision TKA n = 5. 
*p < 0.05. ***p < 0.001.
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showing an increase in α -SMA positive cells in revision TKA, identifies a potential mechanism of action 
for Anakinra in arthrofibrosis that requires further investigation.
In summary there is a significant difference in the architecture and composition of the synovial mem-
brane and infrapatellar fat pad of patients undergoing revision TKA compared to patients undergoing 
primary TKA. Surprisingly, whether revision TKA patients were clinically diagnosed as arthrofibrotic or 
non-arthrofibrotic there were still significant differences in fibrotic markers compared to primary TKA 
suggesting an ongoing fibrotic process is occurring in all revision knees. Further research is required to 
further understand the mechanisms driving tissue remodeling following TKA and to investigate why the 
presence of fibrosis in the knee leads to restricted range of motion in only a limited number of patients.
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